Skip to content

Clinical trials

Phase 1/2 Head and Neck Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1/2 Clear all

178 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20025
20035
20042
20052
20064
20073
20085
200910
20104
20112
20123
20133
20143
20157
20162
201714
201811
201911
202012
20218
20226
202312
20249
20256
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Recruiting32
Terminated23
Unknown status19
Active, not recruiting9
Not yet recruiting8
Withdrawn4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center5
Memorial Sloan Kettering Cancer Center5
National Cancer Institute (NCI)5
Eli Lilly and Company4
Genmab4
Incyte Corporation3
University of Alabama at Birmingham3
Boneca Corporation2
CytomX Therapeutics2
Dana-Farber Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms178
Squamous Cell Carcinoma of Head and Neck56
Neoplasms33
Lung Neoplasms29
Carcinoma, Non-Small-Cell Lung28
Breast Neoplasms27
Ovarian Neoplasms27
Colorectal Neoplasms24
Stomach Neoplasms20
Uterine Cervical Neoplasms20

Trials

Showing 51 to 75 of 178. Each trial links to its page on Pharma Observatory.

78 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.